The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta
NCT05415891 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 333
Last updated 2022-06-13
Summary
This project consists of a pilot trial to assess the preliminary impact of a stigma-reduction training to reduce clinic-level stigma and the You℞ Decision prescribing platform to increase HIV care providers' self-efficacy related to prescribing psychiatric medication for depression, post-traumatic stress disorder (PTSD), and bipolar disorder as well as naltrexone for alcohol use disorder (AUD).
Conditions
- Mental Health Disorder
- Substance Use Disorder
- Stigmatization
- Implementation Science
Interventions
- BEHAVIORAL
-
Modified Health Policy Project (HPP) HIV-Stigma and Discrimination Reduction Training Curriculum
The Health Policy Project (HPP) training curriculum provides participatory training modules that address three key actionable drivers of HIV-stigma. The HPP curriculum was adapted through participatory workshops with the study's community collaborative board, including representatives from the HIV care and advocacy communities as well as community members. The training is a whole-site training to address stigma as a barrier to accessing substance use and mental health services by persons living with HIV. Consequently, staff at all levels (clinical and nonclinical) will be trained on stigma and discrimination as it relates to persons living with HIV in order to reduce stigma-related barriers to mental health and substance use healthcare in Positive Impact Health Centers and increase retention in healthcare services for persons living with HIV.
- DEVICE
-
You℞ Decision prescribing platform
The You℞ Decision prescribing platform is a mobile application that serves as a reference to quickly inform providers about the medications recommended for serious mental health disorders and naltrexone to treat AUD; the appropriate dosing regimen; and potential contraindications or interactions related to antiretroviral therapy medications or other psychiatric medication. Information for the platform is adapted from the Department of Veteran Affairs' Manual for HIV Care in Primary Care settings.
Sponsors & Collaborators
-
SisterLove, Inc.
collaborator OTHER_GOV -
Positive Impact Health Centers
collaborator OTHER -
National Institute of Mental Health (NIMH)
collaborator NIH -
RTI International
lead OTHER
Principal Investigators
-
Courtney Peasant Bonner, PhD · RTI International
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-06-30
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- United States
Study Locations
More Related Trials
-
Training Community Members to Deliver HIV Prevention Programs to Urban Youth
NCT00859144 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Telephone-Delivered Behavioral Treatment to Improve the Quality of Life of Older Adults With HIV
NCT00365690 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Self-Managing HIV and Chronic Disease
NCT01032824 ·Status: COMPLETED ·Phase: NA
-
HIV Prevention Intervention for People Living With HIV/AIDS
NCT01061021 ·Status: COMPLETED ·Phase: PHASE2
-
Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting
NCT02037594 ·Status: COMPLETED ·Phase: NA
-
Personalized Prevention for Couples: A 16-month Digital RCT
NCT05708014 ·Status: COMPLETED ·Phase: NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
NCT06558825 ·Status: RECRUITING ·Phase: NA
-
Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil
NCT00881699 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.
NCT07281378 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Preventing & Treating HIV Comorbidities in India: Multi-tiered Strategy for Women
NCT02319330 ·Status: COMPLETED ·Phase: NA
-
Improving HIV Prevention Skills in People With Serious Mental Illnesses
NCT00356291 ·Status: COMPLETED ·Phase: PHASE2
-
PrEP Affect Regulation Treatment Innovation
NCT04899024 ·Status: COMPLETED ·Phase: NA
-
PATH For Triples Study: Medication and Lifestyle Adherence for HIV+ Patients
NCT02185144 ·Status: COMPLETED ·Phase: NA
-
Stress-Reducing Interventions in HIV+ Patients: Pilot
NCT00599599 ·Status: UNKNOWN ·Phase: NA
-
Effect of HIV/STD Risk Reduction Program on South African Adolescents
NCT00559403 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV
NCT00611429 ·Status: COMPLETED ·Phase: NA
-
Intervention to Improve HIV Self-care Among People Who Inject Drugs
NCT05819411 ·Status: COMPLETED ·Phase: NA
-
Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients
NCT04201288 ·Status: COMPLETED ·Phase: NA
-
Improving Prevention Systems to Reduce Disparities for High Priority Populations
NCT03778164 ·Status: UNKNOWN ·Phase: NA
-
Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and Sexual Health Choices
NCT07173816 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Randomized Trial to Prevent HIV Among Gay Couples
NCT03189394 ·Status: UNKNOWN ·Phase: PHASE1
-
Tailoring Healthy Relationships to Improve HIV Outcomes
NCT05708261 ·Status: RECRUITING ·Phase: NA
-
Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV
NCT02495779 ·Status: COMPLETED ·Phase: NA
-
Improving Provider Counseling Interventions in HIV Practice
NCT00538993 ·Status: COMPLETED ·Phase: NA
-
Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men
NCT01559805 ·Status: COMPLETED ·Phase: NA